These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6137324)

  • 1. Ocular hypertensive response to beta-adrenoceptor agonists.
    Potter DE; Nicholson HT; Rowland JM
    Curr Eye Res; 1982-1983; 2(10):711-9. PubMed ID: 6137324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of timolol and other adrenergic agents on intraocular pressure in the rabbit.
    Vareilles P; Silverstone D; Plazonnet B; Le Douarec JC; Sears ML; Stone CA
    Invest Ophthalmol Vis Sci; 1977 Nov; 16(11):987-96. PubMed ID: 21145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cholinergic drugs and adrenergic drugs on aqueous humor formation in the rabbit eye.
    Miichi H; Nagataki S
    Jpn J Ophthalmol; 1982; 26(4):425-36. PubMed ID: 7166902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization of beta-adrenoceptor subtype involvement in the ocular hypotensive response to beta-adrenergic stimulation.
    Woodward DF; Chen J; Padillo E; Ruiz G
    Exp Eye Res; 1986 Jul; 43(1):61-75. PubMed ID: 2874044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sympathetic nervous system modulates the ocular hypotensive action of MT2-melatonin receptors in normotensive rabbits.
    Alarma-Estrany P; Crooke A; Mediero A; Peláez T; Pintor J
    J Pineal Res; 2008 Nov; 45(4):468-75. PubMed ID: 18673419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steric structure activity relationships of various adrenergic agonists: ocular and systemic effects.
    Rowland JM; Potter DE
    Curr Eye Res; 1981; 1(1):25-35. PubMed ID: 6117417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contributions of adenosine receptor activation to the ocular actions of epinephrine.
    Crosson CE; Petrovich M
    Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2054-61. PubMed ID: 10440261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental studies with timolol: a new ocular hypotensive agent (author's transl)].
    Vareilles P; Schmitt C; Lotti VJ; Le Douarec JC
    J Fr Ophtalmol; 1978 Dec; 1(12):717-21. PubMed ID: 155095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. beta-agonistic bronchodilators: comparison of dose/response in working rat hearts.
    Zimmer G; Dahinten A; Fitzner A; Halbig S; Noll T; Treusch F; Libertus H
    Chest; 2000 Feb; 117(2):519-29. PubMed ID: 10669699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of timolol, terbutaline and forskolin on IOP, aqueous humour formation and ciliary cyclic AMP levels in the bovine eye.
    Shahidullah M; Wilson WS; Millar C
    Curr Eye Res; 1995 Jul; 14(7):519-28. PubMed ID: 7587297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of adrenergic drugs on aqueous cAMP and cGMP and intraocular pressure.
    Rowland JM; Potter DE
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1979; 212(2):65-75. PubMed ID: 44821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of IBMX-enhanced ocular hypotension after adrenergic agonists in the rabbit eye.
    Busch MJ; Hoyng PF
    Graefes Arch Clin Exp Ophthalmol; 1995 May; 233(5):296-301. PubMed ID: 7542619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. R-enantiomer of timolol: a potential selective ocular antihypertensive agent.
    Share NN; Lotti VJ; Gautheron P; Schmitt C; Gross DM; Hall RA; Stone CA
    Graefes Arch Clin Exp Ophthalmol; 1984; 221(5):234-8. PubMed ID: 6092239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of adrenergic agonists and alpha-, beta 1-, beta 2-antagonists on the intraocular pressure and adenylate cyclase activity in the ciliary processes of the rabbit.
    Palkama A; Uusitalo H; Raij K; Uusitalo R
    Acta Ophthalmol (Copenh); 1985 Feb; 63(1):9-15. PubMed ID: 2859730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reproterol--A monomolecular combination of orciprenaline and theophylline: novel aspects of its mode of action in asthma.
    Juergens UR; Stöber M; Vetter H
    Respiration; 1999; 66(3):220-4. PubMed ID: 10364737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical timolol, at conventional, unilateral doses causes bilateral ocular beta-blockade in rabbits.
    Woodward DF; Dowling MC; Feldmann BJ; Chen J
    Exp Eye Res; 1987 Feb; 44(2):319-29. PubMed ID: 2884125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension.
    Easthope SE; Perry CM
    Drugs Aging; 2002; 19(3):231-48. PubMed ID: 12027782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ICI 118,551: an effective ocular hypotensive agent with selectivity for the ciliary process beta 2-adrenoceptor and with minimal cardiac side effects.
    Nathanson JA
    Br J Pharmacol; 1984 Nov; 83(3):821-9. PubMed ID: 6150744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of topical nipradilol, a beta blocking agent with alpha blocking and nitroglycerin-like activities, on intraocular pressure and aqueous dynamics in humans.
    Kanno M; Araie M; Koibuchi H; Masuda K
    Br J Ophthalmol; 2000 Mar; 84(3):293-9. PubMed ID: 10684841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of ocular hypertension induced by adenosine agonists.
    Crosson CE; Gray T
    Invest Ophthalmol Vis Sci; 1996 Aug; 37(9):1833-9. PubMed ID: 8759351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.